- Home
- XRTX vs SXTP Comparison
XRTX vs SXTP Comparison
Compare XRTX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- SXTP
- Stock Information
- Founded
- XRTX 2011
- SXTP 2010
- Country
- XRTX Canada
- SXTP United States
- Employees
- XRTX N/A
- SXTP N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- XRTX Health Care
- SXTP Health Care
- Exchange
- XRTX Nasdaq
- SXTP Nasdaq
- Market Cap
- XRTX 4.2M
- SXTP 5.9M
- IPO Year
- XRTX N/A
- SXTP 2023
- Fundamental
- Price
- XRTX $0.83
- SXTP $1.40
- Analyst Decision
- XRTX
- SXTP Buy
- Analyst Count
- XRTX 0
- SXTP 2
- Target Price
- XRTX N/A
- SXTP $3.00
- AVG Volume (30 Days)
- XRTX 44.1K
- SXTP 78.3K
- Earning Date
- XRTX 08-15-2025
- SXTP 08-13-2025
- Dividend Yield
- XRTX N/A
- SXTP N/A
- EPS Growth
- XRTX N/A
- SXTP N/A
- EPS
- XRTX N/A
- SXTP N/A
- Revenue
- XRTX N/A
- SXTP $984,494.00
- Revenue This Year
- XRTX N/A
- SXTP $81.41
- Revenue Next Year
- XRTX N/A
- SXTP $95.63
- P/E Ratio
- XRTX N/A
- SXTP N/A
- Revenue Growth
- XRTX N/A
- SXTP 128.70
- 52 Week Low
- XRTX $0.66
- SXTP $1.22
- 52 Week High
- XRTX $2.51
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- XRTX 50.73
- SXTP 48.27
- Support Level
- XRTX $0.80
- SXTP $1.33
- Resistance Level
- XRTX $0.86
- SXTP $1.45
- Average True Range (ATR)
- XRTX 0.04
- SXTP 0.09
- MACD
- XRTX 0.00
- SXTP 0.02
- Stochastic Oscillator
- XRTX 50.25
- SXTP 60.66
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.